Recent progress in molecular genetics has strongly influenced nephrology. Gene mutations have been identified which cause various monogenic hereditary renal diseases including Alport syndrome, autosomal dominant polycystic kidney disease, and tubular transporter disorders. The data obtained will be useful not only to develop newmethods of diagnosis and treatment of such particular diseases but also to expand the knowledge of renal physiology and pathophysiology. In addition, genetic factors have been investigated which are involved in the development and progression of more commonrenal diseases such as IgA nephropathy and diabetic nephropathy. There have also been great advances in molecular studies of experimental renal diseases such as Heymannnephritis and in the use of transgenic and knockout mice. In this review we focused on the important achievements made recently in the field of molecular nephrology. (Internal Medicine 36: 81-86, 1997) 
Introduction
Patients with renal failure due to various renal diseases have been increasing in number. Replacement treatments such as dialysis and renal transplantation are effective but costly and still far from compensating for native kidney functions. Therefore, it is one of the urgent medical issues to elucidate the molecular mechanisms of the renal diseases for preventing the deterioration of renal functions. Recent advances in molecular genetics have madea great impact on nephrology. Gene mutations causing monogenic renal diseases (Table 1) have been identified by a method of socalled reverse genetics or by investigating candidate genes that had been speculated to be defective or localized in the genetic loci linked to the diseases. Furthermore, identification of numerouspolymorphicgene markers has also madeit possible to carry out genetical studies of putative polygenie renal diseases such as glomerulonephritis and diabetic nephropathy. In addition, molecular studies on animal renal disease models and the use of transgenic and knockout mice have becomepowerful tools to get insight into the pathogenesis of human renal diseases. In this review we focused on the recent progress in such molecular studies that identified or characterized specific gene products associated with renal diseases.
Alport Syndrome and Thin Basement MembraneDisease
Alport syndrome (AS) is a hereditary progressive nephropathy characterized by lamellation and splitting of the glomerular basement membrane (GBM)and is usually associated with sensorineural deafness and ocular defects. The disease occurs at a gene frequency of 1/5,000 and is transmitted in most families as an X-linked dominant trait (1) . A variety of mutations in the COL4A5gene which encodes the oc5 chain of type IV collagen, a component of the GBM, have been identified in X-linked AS families (2) . The mutations include single base substitutions, large deletions, and other rearrangements such as inversions, insertions, and duplications; but these are dispersed in the gene and no "hot spots" have thus far been identified. In Japanese patients with X-linked AS,only a case whomwe reported was affected by a large deletion (3) but most of the others were due to single base mutations, and small size deletions and insertions (4). Female patients with X-linked AS usually lead a milder clinical course than males, but females with severe phenotypes were found to result from preponderant inactivation of the X chromosome carrying the normal allele (5).
The COL4A3and COL4A4genes that encode the a3 and a4 chains of type IV collagen, respectively, were identified and colocalized in a head-to-head fashion on human chromosome2 (6). Because these chains are also contained in the GBM, mutations in the genes were screened for ASfamilies in which consanguinity suggested autosomal recessive inheritance. Homozygousmutations were found in both genes (7), indicating that there is an autosomal form of AS in addition to the X-linked form.
The association of AS with diffuse esophageal Caused by activating gene mutations.
leiomyomatosis
(DL) has been described (8). The DL-AS patients were found to be affected by gene deletions that involve the 5' ends ofCOL4A5 as well as COL4A6 that encodes a novel oc6(IV) collagen chain and is closely located at the upstream of COL4A5(9). Recently DL-AS was implied to be caused by expression of an abnormal truncated a6(IV) chain rather than its defect by a large deletion of the gene (10). The ocl(IV) and oc2(IV) chains are found ubiquitously in basementmembranes (BMs) butthe a3(IV), o4(IV) and a5(IV) chains have restricted tissue distributions (1 1). However, the a6(IV) chain is absent in the GBMalthough it is colocalized with the a5(IV) chain in many BMs(12). This indicates thatthe oc5(IV) and a6(IV) chains are not always coordinately regulated and excludes COL4A6as a gene mutated in AS. The a3(IV), o4(IV), a5(IV) and a6(IV) chains were found to be absent from all renal BMsin patients with X-linked AS while the al(IV) and oc2(IV) chains were increased (12). The data supports the existence of two independent collagen networks, one for the ocl(IV) and a2(IV) chains and the other for the cc3(IV), cc4(IV), oc5(IV) and oc6(IV) chains. In the GBM, however, the a3(IV), a4(IV) and oc5(IV) chains appear to form a particular network. Coordinate gene expression of the oc3 (IV) , oc4(IV) and a5(IV) chains in the kidney was also supported by an analysis using a canine model of X-linked nephritis with a COL4A5gene mutation (13 identical spectrum of organ involvement but slower development of ESRDthan PKD1families. After long pursuit by positional cloning, the PKD1gene was identified by analyzing a chromosomal translocation in a family with PKD1accompanied by tuberous sclerosis that had been found to result from a defect ofa gene located nearPKD1(24).
Characterization of the breakpoint in 1 6p1 3.3 led to the identification of PKD1in which mutations were found in PKD1 families (24). Cloning of the entire gene (25, 26) and the fulllength CDNA(26, 27) made it possible to predict that the PKD1 product, designated polycystin, consists of 4,303 (26) or 4,302 amino acids (27) that code for a putative transmembrane protein with novel repeat motifs in its extracellular domain. Widespread expression ofPKD1mRNA was seen in human adult tissues, with high levels in the brain and moderate in the kidney (28). Expression of the PKD1protein, polycystin, was localized to the tubular epithelium (28, 29) and glomerular parietal and visceral epithelium (podocytes) (29) in fetal and adult kidney, suggesting that polycystin functions for the maintenance of renal epithelial differentiation and organization (28). In addition, polycystin mRNA and protein expression appears higher in cystic epithelia, indicating that PKD1 does not result from complete loss of the protein (28, 29). Recently the PKD2gene was also identified by positional cloning (30). Expression of the mRNA was shown to be ubiquitous in various tissues. The predicted 968-amino acid sequence of the PKD2protein has six transmembrane spans with intracellular N-and C-termini. The region containing the six transmembrane segments but the N-and C-terminal domains has amino acid similarity with the PKD1protein region that contains its four predicted transmembrane segments. However, the PKD2protein appears more likely to belong to the family of voltage-activated calcium and sodium channels, suggesting that the PKD2protein could also function as an ion channel or pore. Given that the clinical courses of PKD1and PKD2are very similar, it is speculated thatthePKD1 andPKD2 proteins are involved in a commonsignal transduction pathway.
Hereditary Disorders of Tubular Transporters
Nephrogenic diabetes insipidus is characterized by insensitivity of the renal concentrating system to the water-sparing effects of the antidiuretic hormonearginine vasopressin (ADH).
The congenital forms include X-linked recessive and autosomal recessive types. The former type has been found to result from various mutations in a gene (ADHRV2) that encodes the V2 ADHreceptor in the collecting tubular cells since the first report of the mutation (3 1). A male patient of the latter type was also demonstrated to be affected by heterozygous gene mutations (32) of aquaporin-2, a water channel in the collecting tubule (33).
Liddle's syndromeis a rare autosomal dominant form of hypertension characterized by hypokalemia and decreased serum renin activity despite of suppressed secretion of aldosterone. The disease has been speculated to result from increased activity of an amiloride-sensitive epithelial Na+ channel in the cortical collecting tubule which might allow sustained absorption of Na+and result in extracellular volume expansion.
Recently three subunits (a, (3, and y) of the epithelial Na+ channel were cloned (34, 35) and gene mutations in the (3 and y subunits were actually found to cause Liddle's syndrome (36, 37). The activating gene mutations result in the increase in numberof Na+channels at the apical membrane, which would increase renal Na+ absorption and create a predisposition to hypertension (38). In contrast, mutations in the subunits of the Na+ channel which result in the loss of the activity were found in patients with autosomal recessive pseudohypoaldosteronism type 1 (39), a rare salt wasting disease which is characterized by dehydration, hyponatremia, hyperkalemia and metabolic acidosis often in the neonatal period, and actually appears as a clinical mirror image of Liddle's syndrome. Gitelman's syndrome, a variant of Bartter's syndrome, refers to a predominant subset of patients with hypokalemic alkalosis associated with hypocalciuria and hypomagnesemia. The thiazide-sensitive Na-Cl cotransporter of the distal convoluted tubule was cloned (40) and the gene mutation was shown to cause Gitelman's syndrome (41) . Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism were found to be caused by inactivating gene mutations of a recently cloned extracellular Ca2+-sensing receptor that is expressed in the parathyroid and kidney (42) . By contrast, an activating mutation in the gene causes autosomal dominant hypocalcemia (42) . Three hereditary disorders of hypercalciuric nephrolithiasis (Dent's disease, X-linked recessive nephrolithiasis, and Xlinked recessive hypophosphataemic rickets) were found to be caused by mutations of the same gene, CLCN5,which encodes a renal Cl" channel (43) . These disorders show low-molecularweight proteinuria and hypercalciuria, suggesting the presence of tubulopathy.
It remains to be investigated how the Clc hannel impairment is associated with the tubular dysfunction. These hereditary tubular diseases are rare but the identification of the disease-causing genes will contribute to understanding the functions of the gene products and exploring the pathogenesis of other diseases that are more common. For instance, an impaired regulation of the epithelial Na+ channel may participate in the pathogenesis of essential hypertension. Common renal diseases such as glomerulonephritis and diabetic nephropathy have also recently become subject to genetical studies. These diseases are often developed sporadically but some genetic factors are implicated to be involved (44-^-7). The putative genetic factors may be divided into two categories: One is for factors involved in initiating the particular diseases, and the other for those associated with progressing ESRDwhich may be inherited independently of the former ones. As candidates for the first category of factors, HLA allotypes and haplotypes have been intensively studied in patients with glomerulonephritis (45, 46) , although the pathogenetical roles have not been completely determined. The second category of factors, which may be associated with the occurrence of ESRDregardless of the basic diseases, has been suggested in racial and familial studies (47) . Out of these, angiotensin-converting enzyme (ACE) gene polymorphisms have been most studied.
An insertion (I)-deletion (D) polymorphism in intron 16 of the ACEgene is associated with variation in circulating levels
of ACE: The DDgenotype shows the highest ACElevel, followed by the DI, then II genotypes (48) . The D allele is associated with various conditions including myocardial infarction (49) and cardiomyopathy (50) . The D allele was reported to be associated not with development ofIgA nephropathy but with rapid progression of renal failure in the patients (5 1-53). In addition, IgA nephropathy patients with the DD genotype were shownto respond to ACEinhibition therapy with lisinopril for decreasing proteinuria (52), but there is a discordant report showing that enalapril did not lower the degree ofproteinuria in non-diabetic renal disease patients with the DD genotype (54) . The presence ofnephropathy in insulindependent diabetes mellitus (IDDM)was reported to be associated with the D allele (55). However, Schmidt et al indicated that there was no such association in nephropathy both due to IDDMand non-insulin-dependent diabetes mellitus (NIDDM) (56). Onthe other hand, there is a report indicating that the DD genotype appears to be associated with higher urinary albumin excretion in patients with nephropathy in NIDDMpatients (57).
In addition, a recent report by Yoshida et al demonstrated that the DDgenotype has a significant prognostic value for progression ofnephropathy in NIDDM(58). These results suggest that, as in the case ofIgA nephropathy, the ACEgene polymorphism appears to be associated with progression of diabetic nephropathy.
These association studies should be confirmed by investigating more patients whoseclinical features are correctly characterized. Furthermore, affected sib-pair studies using multiplex families may need to be carried out to study the genetic factors as done for other putative polygenic disorders such as IDDM (59) and Crohn' s disease (60).
Progress in the Molecular Study of Experimental Nephrology
Heymannnephritis (HN) is a well-characterized experimental autoimmunemodel of membranousnephropathy, one of the most commonprimary diseases that cause nephrotic syndrome in adults. As a major autoimmunetarget in HN, gp33Owas identified which is located in the clathrin-coated pits of glomerular podocytes and proximal tubular cells. Wehave elucidated the primary structure of rat gp330 by CDNAcloning (61).
gp330, which we renamed megalin, consists of 4,660 amino acids and has a predicted molecular weight of 5 17 kDa without glycosylation. It functions as an endocytic receptor of multiple ligands and is involved in Ca2+ sensing (62). Using recombinant megalin fragments we mappedits pathogenic epitope involved in the formation of immune deposits in HN(63), which would promote the analysis of the molecular mechanisms of HN. Transgenic and gene-targeting technology has become a powerful tool for experimental nephrology (64). First, it has provided information about novel proteins associated with renal diseases: A transgenic mousestrain which showednephrotic syndrome and glomerulosclerosis was developed by a genomic insertion of a single provirus (65). The gene inactivated by the insertion, referred to as Mpvl7, was found to encode a peroxisomal protein producing reactive oxygenspecies (ROS), suggesting a link between peroxisomal ROS production and glomerulosclerosis (66). Second, gene targeting has revealed developmental or physiological functions of targeted gene ' s products in the kidney: Mice deficient for plateletderived growth factor (PDGF)-B or PDGF(3 receptor showed no formation of glomerular tufts apparently because of absence ofmesangial cells, indicating their role in migration ofmesangial cells into glomeruli (67). Third, it has developed new renal disease models: Mutant mice lacking laminin p2, a normal GBM component, revealed albuminuria despite of no apparent renal structural abnormality except for fused foot processes of podocytes, resembling minimal change nephrotic syndrome in humans (68).
Experimental gene transfer into the kidney has been conducted in an attempt to unravel the mechanisms of renal diseases and develop novel methods of the treatment (69). Gene therapy of experimental fibrotic glomerulonephritis was also shownto succeed by skeletal muscle gene expression ofdecorin, an inhibitor of transforming growth factor-(3 1 (70). There are still many technical and ethical problems to be resolved for applying gene transfer in vivo to treatment of humandiseases, but it certainly has the potential to becomean effective therapeutic tool in the future.
Conclusions and Perspectives
Identification of disease-causing or disease-associated genes has strongly influenced the development of clinical methods of diagnosis and treatment of specific renal diseases. It has also expanded our knowledge on renal physiology and pathophysi-ology by analyzing the phenotypes caused by the defected gene products. The knowledge will again give clinical studies feedback on elucidating the pathogenesis of more complex renal diseases. Availability of a large number of polymorphic makers in the whole humangenome also will be a powerful tool for analyzing complex genetic factors which may be involved in various forms of glomerulonephropathy. The analysis of experimental renal disease models and the continued use of transgenic and knockout mice are expected to provide more insight into human disease counterparts. In addition, new techniques developed (7 1) maypromote isolating more genes that are predominantly expressed in the kidney. These genes may be found to regulate critical functions of the kidney in homeostasis of water and electrolytes, metabolism of numerous molecules and synthesis ofhormonesand, in turn, cause certain renal diseases whenmutated.
Bartter's syndrome, featuring salt wasting, hypokalemic alkalosis, hypercalciuria and low blood pressure, was found to be caused by mutations in the Na-K-2C1 cotransporter (NKCC2), a mediator of salt reabsorption in the thick ascending limb of the loop of Henle (72). In the kindreds that show no linkage to the gene, mutations was identified in an ATP-sensitive K+ channel (ROMK)that recycles reasborbed K+ back to the tubular lumen (73). These findings indicate the genetic heterogeneity of Bartter's syndrome and support the physiological role of ROMK in the regulation of the renal NKCC2 activity. 14) Reeders ST. 
